1. Home
  2. JVA vs ITRM Comparison

JVA vs ITRM Comparison

Compare JVA & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coffee Holding Co. Inc.

JVA

Coffee Holding Co. Inc.

HOLD

Current Price

$3.67

Market Cap

21.0M

ML Signal

HOLD

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.37

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JVA
ITRM
Founded
1971
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.0M
24.3M
IPO Year
2005
2018

Fundamental Metrics

Financial Performance
Metric
JVA
ITRM
Price
$3.67
$0.37
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.00
AVG Volume (30 Days)
35.5K
731.7K
Earning Date
01-30-2026
02-06-2026
Dividend Yield
N/A
N/A
EPS Growth
64.91
N/A
EPS
0.32
N/A
Revenue
$89,748,681.00
$390,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$325.95
P/E Ratio
$11.21
N/A
Revenue Growth
17.92
N/A
52 Week Low
$2.75
$0.36
52 Week High
$9.93
$2.10

Technical Indicators

Market Signals
Indicator
JVA
ITRM
Relative Strength Index (RSI) 49.02 32.72
Support Level $3.31 $0.44
Resistance Level $3.74 $0.49
Average True Range (ATR) 0.17 0.04
MACD 0.03 0.00
Stochastic Oscillator 80.77 0.78

Price Performance

Historical Comparison
JVA
ITRM

About JVA Coffee Holding Co. Inc.

Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: